Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2026-03-02 00:00:00 ET · period of report 2026-03-02 · accession 0001628280-26-013394 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | 2026-03-02 | MDGL | Dier Mardi | EVP, CFO | S - Sale | $427.21 | -1,183 | 9,257 | -11% | -$505.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | S | D | 1,183 | $427.21 | 9,257 | D | — | — |